Product Information

METRONIDAZOLE 375 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $7.3080 per EA under NDC 62135083650. Its NADAC has been published 108 times since Jun 5, 2024.

The High Outlier badge above means this manufacturer's average price in the Metronidazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

METRONIDAZOLE 375 MG CAPSULE

Metronidazole
$7.3080per EA
High Outlier

Strength

375 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135083650

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

1/21/2026

Active Ingredients

METRONIDAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA076522

On Market Since

1/29/2004

Pharmacological Classes

Price Statistics

The NADAC for METRONIDAZOLE 375 MG CAPSULE has been published 108 times since Jun 5, 2024, and over the history we have for it it has risen 13.9%. The table below summarizes its recorded NADAC range and movement.

Current price$7.3080 per EA
All-time high$8.0061 (Apr 16, 2025)
All-time low$6.1014 (Jul 17, 2024)
52-week high$7.8041
52-week low$7.3080
Median price$7.3163
Average price$7.2795
Largest weekly change+12.8% (Nov 20, 2024)
Weeks tracked108
Tracking sinceJun 5, 2024

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-4.1%

1Y

-6.4%

3Y

N/A

5Y

N/A

All

+13.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Metronidazole market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of METRONIDAZOLE 375 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 375 MG CAPSULE, manufactured by Chartwell RX LLC, is $7.3080 per EA (NDC 62135083650), effective Jun 24, 2026.

How has the price of METRONIDAZOLE 375 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for METRONIDAZOLE 375 MG CAPSULE has risen 13.9%. It has been tracked across 108 weekly CMS publications since Jun 5, 2024.

What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 375 MG CAPSULE?

Since Jun 5, 2024, the NADAC for METRONIDAZOLE 375 MG CAPSULE has ranged from a low of $6.1014 (Jul 17, 2024) to a high of $8.0061 (Apr 16, 2025), with a median of $7.3163 per EA.

Are there cheaper alternatives to METRONIDAZOLE 375 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of METRONIDAZOLE 375 MG CAPSULE, so no direct lower-cost alternative is listed.

Who manufactures METRONIDAZOLE 375 MG CAPSULE?

METRONIDAZOLE 375 MG CAPSULE (NDC 62135083650) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.